Long-term continuous therapy should be avoided, particularly in children, in whom adrenal suppression may occur readily. If Elopro is required for use in children, courses should be limited to 5 days, and weekly evaluation should be done.
The face, more than other areas of the body, may exhibit atrophic changes after prolonged treatment with potent topical corticosteroids.
If applied to the eyelids, care is needed to ensure that Elopro does not enter the eye, as glaucoma might result. Topical antibiotics should be given whenever treating inflammatory lesions which are prone to infection.
Caution should be exercised when given to pregnant and nursing women.